Author:
Mintziori Gesthimani,Watt Torquil,Veneti Stavroula,Panagiotou Athanasios,Pournaras Dimitri J.,Feldt-Rasmussen Ulla,Rasmussen Åse Krogh,Hegedüs Laszlo,Bonnema Steen Joop,Bjorner Jakob Bue,Kita Marina,Goulis Dimitrios G.
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Endocrinology, Diabetes and Metabolism
Reference35 articles.
1. Biondi B, Fazio S, Carella C et al (1994) Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab 78:1028–1033
2. Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hording M, Perrild H, Waldemar G (2004) Impaired health-related quality of life in Graves’ disease. A prospective study. Eur J Endocrinol 151:549–555
3. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM (1997) Quality of life in patients with Graves’ ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 7:885–889
4. Petersen K, Bengtsson C, Lapidus L, Lindstedt G, Nystrom E (1990) Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch Intern Med 150:2077–2081
5. Klein I, Trzepacz PT, Roberts M, Levey GS (1988) Symptom rating scale for assessing hyperthyroidism. Arch Intern Med 148:387–390
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献